Editors

Editors-in-Chief

Arjan W. Griffioen
Dept of Medical Oncology
VU University Medical Center
De Boelelaan 1117
1082 HV Amsterdam
The Netherlands

Patrycja Nowak-Sliwinska
School of Pharmaceutical Sciences
University of Geneva (UNIGE)
Rue Michel-Servet 1,
1211 Geneva 4
Switzerland


Editorial Board

C. Abbadie, Lille, France;
G. Bánfalvi, Debrecen, Hungary;
P. Bouillet, Parkville, VIC, Australia;
W. Brune, Hamburg, Germany;
C. Culmsee, Marburg, Germany;
W. Declercq, Ghent, Belgium;
P. Domingos, Lisbon, Portugal;
H.C.A. Drexler, Münster, Germany;
E.E. Dupont-Versteegden, Lexington, KY, USA;
F. Gao, Xi’an, China;
A.B. Gustafsson, La Jolla, CA, USA;
C. Hawkins, Victoria, Australia;
K.H. Heldin,
Uppsala, Sweden;
J. Jonkers, Amsterdam, The Netherlands;
O. Kepp, Villejuif, France;
D. Kessel, Michigan, MI, USA;
P. Krimpenfort, Amsterdam, The Netherlands;
G. Kroemer, Villejuif, France;
G. Krumschnabel, Innsbruck, Austria;
F.A.E. Kruyt, Groningen, The Netherlands;
D. Krysko, Ghent, Belgium;
N. Kyprianou,
Lexington, KY, USA;
R.A. Lockshin,
Jamaica, NY, USA;
W. Malorni, Rome, Italy;
T.J. McDonnell, Houston, TX, USA;
R. Mirzayans, Edmonton, Alberta, Canada;
H.W. Niessen, Amsterdam, The Netherlands;
G. Packham, Southampton, UK;
H.H. Park,
Gyeonsan, S.Korea;
R.B. Ray,
St.Louis, MO, USA;
J.J. Reiners, Detroit, MI, USA;
G. Rousseau, Montreal, Canada;
T. Sarna, Krakow, Poland;
A.D. Schimmer, Toronto, Canada;
H.-U. Simon, Bern, Switzerland;
L. Smit, Amsterdam, The Netherlands;
S.A. Susin, Paris, France;
D. Tang, Dallas, USA;
K.L. Tyler, Denver, CO, USA;
D.L. Vaux, Victoria, Australia;
A. Villunger,
Innsbruck, Austria;
M.C. Vissers, Christchurch, New Zealand;
O.H. Voss, Columbus, OH, USA;
F. Wandosell, Madrid, Spain;
N.J. Waterhouse,
Brisbane, Australia;
L. Yang, Atlanta, GA, USA;
Z. Zakeri, Flushing, NY, USA;
L. Zhang, Durham, NC, USA;
B. Zhivotovsky, Stockholm, Sweden;
I. Ziv, Petah-Tiqva, Israel;